Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combining Radiation Therapy With Anti-PD-1 for Patients With Advanced Hepatocellular Carcinoma (RT+PD-1-HCC)

NCT04193696 is registered in ClinicalTrials.gov with Guangxi Medical University as lead sponsor.

NCT NCT04193696
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04193696 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combining Radiation Therapy With Anti-PD-1 for Patients With Advanced Hepatocellular Carcinoma (RT+PD-1-HCC)
Lead sponsor
Guangxi Medical University
Phase
Phase 2
Overall status
Unknown status
Start date
January 10, 2020
Completion date
July 30, 2020
Enrollment
39 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma